已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysis

肌萎缩 医学 慢性阻塞性肺病 置信区间 内科学 物理疗法 生活质量(医疗保健) 荟萃分析 肺病 老年学 护理部
作者
Walter Sepúlveda‐Loyola,Christian Robert Osadnik,Steven Phu,Andrea Akemi Morita,Gustavo Duque,Vanessa Suziane Probst
出处
期刊:Journal of Cachexia, Sarcopenia and Muscle [Springer Science+Business Media]
卷期号:11 (5): 1164-1176 被引量:356
标识
DOI:10.1002/jcsm.12600
摘要

Sarcopenia prevalence and its clinical impact are reportedly variable in chronic obstructive pulmonary disease (COPD) due partly to definition criteria. This review aimed to identify the criteria used to diagnose sarcopenia and the prevalence and impact of sarcopenia on health outcomes in people with COPD. This review was registered in PROSPERO (CRD42018092576). Five electronic databases were searched to August 2018 to identify studies related to sarcopenia and COPD. Study quality was assessed using validated instruments matched to study designs. Sarcopenia prevalence was determined using authors' definitions. Comparisons were made between people who did and did not have sarcopenia for pulmonary function, exercise capacity, quality of life, muscle strength, gait speed, physical activity levels, inflammation/oxidative stress, and mortality. Twenty-three studies (70% cross-sectional) from Europe (10), Asia (9), and North and South America (4) involving 9637 participants aged ≥40 years were included (69.5% men). Sarcopenia criteria were typically concordant with recommendations of hEuropean and Asian consensus bodies. Overall sarcopenia prevalence varied from 15.5% [95% confidence interval (CI) 11.8-19.1; combined muscle mass, strength, and/or physical performance criteria] to 34% (95%CI 20.6-47.3; muscle mass criteria alone) (P = 0.009 between subgroups) and was greater in people with more severe [37.6% (95%CI 24.8-50.4)] versus less severe [19.1% (95%CI 10.2-28.0)] lung disease (P = 0.020), but similar between men [41.0% (95%CI 26.2-55.9%)] and women [31.9% (95%CI 7.0-56.8%)] (P = 0.538). People with sarcopenia had lower predicted forced expiratory volume in the first second (mean difference -7.1%; 95%CI -9.0 to -5.1%) and poorer exercise tolerance (standardized mean difference -0.8; 95%CI -1.4 to -0.2) and quality of life (standardized mean difference 0.26; 95%CI 0.2-0.4) compared with those who did not (P < 0.001 for all). No clear relationship was observed between sarcopenia and inflammatory or oxidative stress biomarkers. Incident mortality was unreported in the literature. Sarcopenia is prevalent in a significant proportion of people with COPD and negatively impacts upon important clinical outcomes. Opportunities exist to optimize its early detection and management and to evaluate its impact on mortality in this patient group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
许右完成签到,获得积分10
刚刚
无花果的应助被AdamJie采纳,获得10
2秒前
klee的应助被3921337477采纳,获得10
3秒前
Orange的应助被3921337477采纳,获得10
3秒前
4秒前
小媛发布了新的文献求助10
4秒前
夏夏完成签到 ,获得积分10
5秒前
guofuyan完成签到 ,获得积分10
5秒前
5秒前
6秒前
初景的应助被DW采纳,获得20
6秒前
7秒前
江枫渔火完成签到 ,获得积分0
8秒前
Bowman完成签到,获得积分0
9秒前
10秒前
淡然新竹发布了新的文献求助10
10秒前
LiShan完成签到 ,获得积分10
10秒前
u964071发布了新的文献求助60
11秒前
13秒前
余叶发布了新的文献求助10
13秒前
乐乐的应助被刻苦乐天采纳,获得10
14秒前
槐序深巷完成签到 ,获得积分10
15秒前
酒酿樱桃子完成签到,获得积分10
15秒前
可颂完成签到 ,获得积分10
16秒前
alex的应助被洋芋二号采纳,获得10
17秒前
3921337477的应助被u611408采纳,获得60
17秒前
夏天完成签到 ,获得积分10
19秒前
wsyyyyy完成签到 ,获得积分10
20秒前
墨痕完成签到,获得积分10
21秒前
21秒前
21秒前
sora98完成签到 ,获得积分0
22秒前
momo完成签到,获得积分10
22秒前
科研小小怪完成签到 ,获得积分10
26秒前
刻苦乐天发布了新的文献求助10
27秒前
28秒前
田様的应助被淡然新竹采纳,获得10
29秒前
余叶完成签到,获得积分10
29秒前
30秒前
乐乐的应助被3921337477采纳,获得10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184867
求助须知:如何正确求助?哪些是违规求助? 9573803
关于积分的说明 21833148
捐赠科研通 7782177
什么是DOI,文献DOI怎么找? 3434414
关于科研通互助平台的介绍 2558563
邀请新用户注册赠送积分活动 2481067